Separation Agreements in the Health Care Equipment & Supplies Industry
320 Contracts & Agreements
- Abbott Laboratories (1 contract)
- ABIOMED Inc (1)
- Accelerate Diagnostics, Inc (2)
- ACCURAY INC (10)
- Acutus Medical, Inc. (1)
- AdvanSource Biomaterials Corp (1)
- AETHLON MEDICAL INC (1)
- AIRXPANDERS INC (1)
- Align Technology (4)
- ALLOS THERAPEUTICS INC (3)
- Alphatec Holdings, Inc. (2)
- Angiodynamics Inc (3)
- Apollo Endosurgery, Inc. (5)
- APPYEA, INC (1)
- Apyx Medical Corp (3)
- AquaMed Technologies, Inc. (1)
- Arch Therapeutics, Inc. (1)
- Arno Therapeutics, Inc (1)
- Audentes Therapeutics, Inc. (2)
- Avanos Medical Inc (1)
- Avinger Inc (2)
- AxoGen, Inc. (2)
- BARRIER THERAPEUTICS INC (2)
- Bausch & Lomb Corp (4)
- Baxter International Inc. (2)
- Bellerophon Therapeutics, Inc. (1)
- BIOLASE, INC (6)
- BIOMIMETIC THERAPEUTICS, INC. (1)
- Bionik Laboratories Corp. (3)
- Bioventus Inc. (1)
- Bluejay Diagnostics, Inc. (1)
- Boston Scientific (2)
- Cantel Medical Corporation (1)
- Cardiovascular Systems Inc (6)
- Cascadian Therapeutics, Inc. (1)
- CHEMBIO DIAGNOSTICS, INC. (1)
- CHF Solutions, Inc. (5)
- Colfax CORP (1)
- CORNERSTONE THERAPEUTICS INC (2)
- CryoLife, Inc. (4)
- Cryoport, Inc. (1)
- Cutera, Inc. (2)
- Cytosorbents Corp (1)
- Dare Bioscience, Inc. (4)
- DarioHealth Corp. (1)
- DELCATH SYSTEMS, INC. (1)
- Dentsply Sirona (3)
- DYNATRONICS CORP (4)
- Eargo, Inc. (1)
- Echo Therapeutics, Inc. (1)
- EKSO BIONICS HOLDINGS, INC. (1)
- Electromed, Inc. (2)
- Embecta Corp. (1)
- ENDOLOGIX INC (1)
- Envista Holdings Corp (3)
- ERBA Diagnostics, Inc. (1)
- ESTABLISHMENT LABS HOLDINGS INC. (1)
- GenMark Diagnostics, Inc. (5)
- GI DYNAMICS, INC. (1)
- Haemonetics (1)
- HealthCor Catalio Acquisition Corp. (1)
- HELIUS MEDICAL TECHNOLOGIES, INC. (3)
- Heska Corporation (7)
- Hill-Rom Holdings Inc. (6)
- Hologic (8)
- ICU Medical (1)
- IDEXX Laboratories (1)
- IMARX THERAPEUTICS INC (2)
- InspireMD, Inc. (2)
- Insys Therapeutics, Inc. (1)
- Integer Holdings Corporation (4)
- Integra Lifesciences Holdings (3)
- INTRICON CORP (1)
- Invacare Corporation (4)
- IRADIMED CORP (3)
- iRhythm Technologies, Inc. (1)
- IRIDEX CORP (2)
- KEWAUNEE SCIENTIFIC CORP (3)
- Lantheus Holdings, Inc. (2)
- LENSAR, Inc. (1)
- LivaNova (4)
- Longview Acquisition Corp. (3)
- Lucira Health, Inc. (1)
- MELINTA THERAPEUTICS, INC. (3)
- Meridian Bioscience, Inc. (4)
- Merit Medical Systems, Inc. (6)
- MINERVA SURGICAL INC (1)
- MRI INTERVENTIONS, INC. (2)
- MYOMO INC (2)
- NanoVibronix, Inc. (1)
- Natus Medical Incorporated (1)
- Neogen Corporation (2)
- Neumora Therapeutics, Inc. (1)
- NeuroMetrix, Inc. (1)
- NEVRO CORP (5)
- NON INVASIVE MONITORING SYSTEMS INC (1)
- NOVELION THERAPEUTICS INC. (3)
- NuVasive Inc (6)
- Ocata Therapeutics, Inc. (1)
- Orexigen Therapeutics, Inc. (2)
- OSIRIS THERAPEUTICS, INC. (3)
- Oxford Immunotec Global PLC (1)
- OZOP SURGICAL CORP. (1)
- PAVmed Inc. (1)
- Precision Therapeutics Inc. (3)
- Presbia PLC (1)
- PRO DEX INC (4)
- Pulse Biosciences, Inc. (1)
- Q Therapeutics, Inc. (1)
- Quotient Ltd (3)
- ReShape Lifesciences Inc. (1)
- Restoration Robotics, Inc. (5)
- ReWalk Robotics Ltd. (1)
- RTI Surgical Holdings, Inc. (2)
- RTI SURGICAL, INC. (3)
- Sandbridge Acquisition Corp (1)
- SANUWAVE Health, Inc. (2)
- SeaSpine Holdings Corp (1)
- SECOND SIGHT MEDICAL PRODUCTS INC (2)
- Semler Scientific, Inc. (1)
- ShockWave Medical, Inc. (6)
- Sientra, Inc. (3)
- STAAR SURGICAL CO (1)
- STEMLINE THERAPEUTICS INC (1)
- STRATA Skin Sciences, Inc. (1)
- Stryker Corp. (2)
- TANDEM DIABETES CARE INC (1)
- Teleflex Inc (1)
- The Cooper Companies (2)
- TRANSENTERIX INC. (1)
- VAPOTHERM INC (3)
- Varex Imaging Corporation (1)
- Varian Medical Systems (2)
- VERMILLION, INC. (4)
- ViewRay, Inc. (9)
- VIVEVE MEDICAL, INC. (1)
- West Pharmaceutical Services (1)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (1)
- Xtant Medical Holdings, Inc. (1)
- Zimmer Biomet Holdings (2)
- ZimVie Inc. (1)
- Zosano Pharma Corp (1)
- ZYNEX INC (1)
- Separation Agreement by and between the Registrant and John Dunlop, Ph.D (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
- Separation Agreement, executed as of August 18, 2023, entered into by and between Tandem Diabetes Care, Inc. and Brian Hansen (TANDEM DIABETES CARE INC, Filed With SEC on August 18, 2023)
- Separation Agreement and Release, dated April 1, 2023 by and among Semler Scientific, Inc. and Douglas Murphy-Chutorian (Semler Scientific, Inc., Filed With SEC on August 14, 2023)
- Separation and Release Agreement, dated June 23, 2023, by and between Eargo, Inc. and Christian Gormsen (Eargo, Inc., Filed With SEC on August 10, 2023)
- Separation Agreement and General Release between DH Dental Employment Services LLC and Jean-Claude Kyrillos (Envista Holdings Corp, Filed With SEC on August 2, 2023)
- Separation Agreement, dated June 30, 2023, by and between Niamh Pellegrini and the Company (NEVRO CORP, Filed With SEC on August 1, 2023)
- Transition and Separation Agreement, dated May 23, 2023, by and between the Company and Kevin A. Richardson, II (SANUWAVE Health, Inc., Filed With SEC on May 30, 2023)
- Separation Agreement, dated as of May 4, 2023, by and between Bellerophon Therapeutics, Inc. and Nicholas Laccona (Bellerophon Therapeutics, Inc., Filed With SEC on May 5, 2023)
- Severance and Separation Agreement dated January 10, 2023 by and between Avanos Medical, Inc. and William D. Haydon (Avanos Medical Inc, Filed With SEC on May 3, 2023)
- Separation Agreement, dated as of November 29, 2022, by and between the company and Rick A. Cassiday (Invacare Corporation, Filed With SEC on April 14, 2023)
- Separation Agreement and Release between Kenneth Reali and Bioventus Inc., dated April 4, 2023 (Bioventus Inc., Filed With SEC on April 5, 2023)
- Amended and Restated Separation Agreement dated December 22, 2022 between Bausch + Lomb Corporation and Joseph C. Papa (Bausch & Lomb Corp, Filed With SEC on February 22, 2023)
- Separation Agreement, dated as of February 6, 2023, by and between Hyperfine, Inc. and Neela Paykel (HealthCor Catalio Acquisition Corp., Filed With SEC on February 8, 2023)
- Termination of Employment and Separation Agreement dated January 23, 2023 by and between Dror Bacher and Labstyle Innovation Ltd (DarioHealth Corp., Filed With SEC on January 27, 2023)
- Separation and Release Agreement, dated December 27, 2022, by and between the Company and David Clapper (MINERVA SURGICAL INC, Filed With SEC on December 28, 2022)
- Separation Agreement and Release, dated December 8, 2022, by and between the Company and Ron Price (Accelerate Diagnostics, Inc, Filed With SEC on December 13, 2022)
- Separation Agreement and General Release, entered into December 5, 2022, between Invacare Corporation and Matthew E. Monaghan (Invacare Corporation, Filed With SEC on December 9, 2022)
- Separation Agreement and General Release and Waiver, dated December 2, 2022, between Sanara MedTech Inc. and Shawn M. Bowman (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on December 6, 2022)
- Separation Agreement and Release between Aspira Womens Health Inc. and Robert Beechey dated November 10, 2022 (VERMILLION, INC., Filed With SEC on November 10, 2022)
- Separation and General Release Agreement by and between Registrant and Pratip Dastidar, dated September 2, 2022 (ESTABLISHMENT LABS HOLDINGS INC., Filed With SEC on November 9, 2022)
- Separation Agreement dated July 19, 2022 between Bausch + Lomb Corporation and Joseph C. Papa (Bausch & Lomb Corp, Filed With SEC on November 2, 2022)
- Separation Agreement and General Release, dated September 23, 2022, by and between Glenn Coleman, Integra LifeSciences Corporation and Integra LifeSciences Holdings Corporation (Integra Lifesciences Holdings, Filed With SEC on September 23, 2022)
- Transition and Separation Agreement dated September 15, 2022 by and between J. Melville Engle and Predictive Oncology Inc (Precision Therapeutics Inc., Filed With SEC on September 16, 2022)
- Amendment No. 1 to the Separation and Distribution Agreement, dated as of August 31, 2022, by and among 3M Company, Garden SpinCo Corporation and Neogen Corporation (Neogen Corporation, Filed With SEC on September 1, 2022)
- Separation Agreement dated as of August 26, 2022, by and between Ron Frost and Merit Medical Systems, Inc (Merit Medical Systems, Inc., Filed With SEC on September 1, 2022)
- Separation Agreement, dated June 30, 2022, by and between the Company and David Whitescarver (Cardiovascular Systems Inc, Filed With SEC on August 18, 2022)
- Separation Agreement, dated June 6, 2022, by and between the Company and Rhonda Robb (Cardiovascular Systems Inc, Filed With SEC on August 18, 2022)
- Separation and Release Agreement dated August 11, 2022 (Sandbridge Acquisition Corp, Filed With SEC on August 11, 2022)
- Separation Agreement, dated March 8, 2022, by and between the Company and Ori Gon (ReWalk Robotics Ltd., Filed With SEC on May 13, 2022)
- Separation Agreement between the Company and Vince Burgess (Acutus Medical, Inc., Filed With SEC on May 12, 2022)
- Amended and Restated Form of Separation Pay Agreement for Executive Officers (Other than CEO) (ShockWave Medical, Inc., Filed With SEC on May 9, 2022)
- Amended and Restated Separation Pay Agreement with Doug Godshall (ShockWave Medical, Inc., Filed With SEC on May 9, 2022)
- Amendment to Master Separation Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of April 28, 2022 (Bausch & Lomb Corp, Filed With SEC on April 28, 2022)
- Separation Pay Agreement Effective as of March 24, 2022 Between Vapotherm, Inc. and Joseph Army (VAPOTHERM INC, Filed With SEC on April 12, 2022)
- Separation Pay Agreement Effective as of March 24, 2022 Between Vapotherm, Inc. and John Landry (VAPOTHERM INC, Filed With SEC on April 12, 2022)
- Separation Pay Agreement Effective as of March 24, 2022 Between Vapotherm, Inc. and Gregoire Ramade (VAPOTHERM INC, Filed With SEC on April 12, 2022)
- Separation and Distribution Agreement, dated April 4, 2022, between Enovis Corporation and ESAB Corporation (Colfax CORP, Filed With SEC on April 8, 2022)
- Separation and Distribution Agreement, dated as of March 31, 2022, by and between Embecta and BD (Embecta Corp., Filed With SEC on April 6, 2022)
- Separation Agreement between Bluejay Diagnostics, Inc. and Gordon Kinder (Bluejay Diagnostics, Inc., Filed With SEC on April 1, 2022)
- Master Separation Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Bausch & Lomb Corp, Filed With SEC on March 31, 2022)
